Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.
Huang, A., Joseph-McCarthy, D., Lovering, F., Sun, L., Wang, W., Xu, W., Zhu, Y., Cui, J., Zhang, Y., Levin, J.I.(2007) Bioorg Med Chem 15: 6170-6181
- PubMed: 17606376
- DOI: https://doi.org/10.1016/j.bmc.2007.06.031
- Primary Citation of Related Structures:
2PJT - PubMed Abstract:
A series of beta-sulfonyl hydroxamate TACE inhibitors, bearing a butynylamino or a butynyloxy P1' group, was designed and synthesized. Of the compounds investigated, 22 has excellent potency against isolated TACE enzyme, shows good selectivity over MMP-2 and MMP-13, and oral activity in an in vivo mouse model of TNF-alpha production.
Organizational Affiliation:
Chemical and Screening Sciences, Wyeth Research, 200 CambridgePark Drive, Cambridge, MA 02140, USA. ahuang@wyeth.com